West Syndrome Market - Top Companies and Manufacturers

Companies Dominating the West Syndrome Landscape

Marinus Pharmaceuticals, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
SK Biopharmaceuticals Co., Ltd.
Alkem Laboratories Ltd.
Supernus Pharmaceuticals, Inc.
Eisai Co., Ltd.
Abbott Laboratories
Upsher-Smith Laboratories, LLC.
Pfizer Inc.
H. Lundbeck A/S
UCB S.A.

Browse Key Market Insights with Data Illustration:

West Syndrome Market Size, Forecast Report 2025-2037

In the News

Eisai Co., Ltd. to announce its first presentation with Merck & Co., Inc. associated with the Phase 3 LEAP-002 trial investigating LENVIMA, a receptor tyrosine, orally available and discovered by Eisai. Furthermore, the anti-PD-1 therapy, plus KEYTRUSA, from Merck & Co., Inc., is also introduced as a first-line treatment for uHCC.
SK Biopharmaceuticals Co., Ltd. to announce the result of the long-term randomized open-label extension (OLE). The company is focused on treatment development for central nervous system (CNS) disorders. Data analyzed in the OLE phase was taken from nearly 335 adult patients having focal seizures. from nearly 355 adult patients having focal seizures.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of west syndrome is estimated at USD 1.21 billion.

The west syndrome market size was valued at USD 1.11 billion in 2024 and is likely to cross USD 2.17 billion by 2037, registering more than 5.3% CAGR during the forecast period i.e., between 2025-2037. Higher prevalence of drug seizures and significant growth in imaging technology will boost the market growth.

North America industry is set to hold largest revenue share by 2037, attributed to escalation in the number of people living with traumatic brain injuries.

The major players in the market are Marinus Pharmaceuticals, Inc., SK Biopharmaceuticals Co., Ltd., Alkem Laboratories Ltd., Supernus Pharmaceuticals, Inc., Eisai Co., Ltd., Abbott Laboratories, Upsher-Smith Laboratories, LLC., Pfizer Inc., H. Lundbeck A/S, UCB S.A.

West Syndrome Market - Top Companies and Manufacturers

Companies Dominating the West Syndrome Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the west syndrome market worth?

Why is the demand for west syndrome growing?

Which region dominated the majority of west syndrome industry share?

Who are the top west syndrome companies?